TXN: Other company developments

Item 8.01. Other Events Issuance of $2,000,000,000 of Notes On November 9, 2026, Texas Instruments Incorporated (“Texas Instruments”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its 5.000% Notes due 2028 (the “2028 Notes”), $500,000,000 aggregate principal amount of its 5.350% Notes due 2031 (the “2031 Notes”), $500,000,000 aggregate principal amount of its 5.500% Notes due 2033 (the “2033 Notes”), and $500,000,000 aggregate principal amount of its 5.750% Notes due 2036 (the “2036 Notes” and, together with the 2028 Notes, 2031 Notes and 2033 Notes, the “Notes”), pursuant to an underwriting agreement filed herewith as Exhibit 1.1 dated October 26, 2026 among Texas Instruments and J.P. Morgan Securities LLC, Citigroup Global Markets Inc., BofA Securities, Inc. and U.S. Bancorp Investments, Inc., as representatives of the several underwriters named therein. The Notes were issued pursuant to an Indenture dated as of May 23, 2011 (the “Indenture”) between Texas Instruments and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee, and an Officers’ Certificate issued pursuant thereto. The Notes were offered pursuant to Texas Instruments’ Registration Statement on Form S-3 filed on February 14, 2025 (Reg. No. 333-284977), including the prospectus contained therein, and a related preliminary prospectus supplement dated October 26, 2026 and a prospectus supplement dated October 26, 2026. The material terms and conditions of the Notes are set forth in the Indenture filed as Exhibit 4.2 to the Current Report of Texas Instruments on Form 8-K dated May 23, 2011 and the Officers’ Certificate filed herewith as Exhibit 4.1 and incorporated by reference herein. 2 Item 9.01 Financial State